Skip to content
TrialScanner

NCT04318145

Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects

Phase 2TerminatedPTNLead

Registry record

Lead sponsor
Palatin Technologies, Inc
Conditions
Heart Failure With Preserved Ejection Fraction
Primary completion
Dec 8, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04318145 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04318145: Study to Evaluate Sex... | TrialScanner